abstract |
The present invention relates to a composition for detecting markers for diagnosing HER2 inhibitor resistant cancer, a diagnostic kit comprising the same, and a method for detecting markers. More particularly, the present invention relates to a method for detecting a HER2 inhibitor against a HER2 inhibitor The present invention relates to a composition for detecting a marker for HER2 inhibitor-resistant cancer, which is capable of judging resistance of a cancer patient more easily and with a remarkably high reliability, a diagnostic kit including the same, and a method for detecting a marker. |